Literature DB >> 21735174

Spread of X-chromosome inactivation into chromosome 15 is associated with Prader-Willi syndrome phenotype in a boy with a t(X;15)(p21.1;q11.2) translocation.

Satoru Sakazume1, Hirofumi Ohashi, Yuki Sasaki, Naoki Harada, Katsumi Nakanishi, Hidenori Sato, Mitsuru Emi, Kazushi Endoh, Ryoichi Sohma, Yasuhiro Kido, Toshiro Nagai, Takeo Kubota.   

Abstract

X-chromosome inactivation (XCI) is an essential mechanism in females that compensates for the genome imbalance between females and males. It is known that XCI can spread into an autosome of patients with X;autosome translocations. The subject was a 5-year-old boy with Prader-Willi syndrome (PWS)-like features including hypotonia, hypo-genitalism, hypo-pigmentation, and developmental delay. G-banding, fluorescent in situ hybridization, BrdU-incorporated replication, human androgen receptor gene locus assay, SNP microarrays, ChIP-on-chip assay, bisulfite sequencing, and real-time RT-PCR were performed. Cytogenetic analyses revealed that the karyotype was 46,XY,der(X)t(X;15)(p21.1;q11.2),-15. In the derivative chromosome, the X and half of the chromosome 15 segments showed late replication. The X segment was maternal, and the chromosome 15 region was paternal, indicating its post-zygotic origin. The two chromosome 15s had a biparental origin. The DNA methylation level was relatively high in the region proximal from the breakpoint, and the level decreased toward the middle of the chromosome 15 region; however, scattered areas of hypermethylation were found in the distal region. The promoter regions of the imprinted SNRPN and the non-imprinted OCA2 genes were completely and half methylated, respectively. However, no methylation was found in the adjacent imprinted gene UBE3A, which contained a lower density of LINE1 repeats. Our findings suggest that XCI spread into the paternal chromosome 15 led to the aberrant hypermethylation of SNRPN and OCA2 and their decreased expression, which contributes to the PWS-like features and hypo-pigmentation of the patient. To our knowledge, this is the first chromosome-wide methylation study in which the DNA methylation level is demonstrated in an autosome subject to XCI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735174     DOI: 10.1007/s00439-011-1051-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  35 in total

1.  Molecular evidence for a relationship between LINE-1 elements and X chromosome inactivation: the Lyon repeat hypothesis.

Authors:  J A Bailey; L Carrel; A Chakravarti; E E Eichler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Switch in X-inactivation in a JAK2 V617F-negative case of polycythemia vera with two acquired X-autosome translocations.

Authors:  Kalliopi N Manola; Chryssa Stavropoulou; Vasileios N Georgakakos; Katerina Zoi; Markos Fisfis; Ilias Evmorfiadis; Christine Zoi; Gabriel E Pantelias; Katy Stefanoudaki; Constantina Sambani
Journal:  Leuk Res       Date:  2007-01-03       Impact factor: 3.156

Review 3.  Functional disomies of the X chromosome influence the cell selection and hence the X inactivation pattern in females with balanced X-autosome translocations: a review of 122 cases.

Authors:  M Schmidt; D Du Sart
Journal:  Am J Med Genet       Date:  1992-01-15

4.  An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivation.

Authors:  George S Vassiliou; Peter J Campbell; Juan Li; Ian Roberts; Soheila Swanton; Brian J P Huntly; Nasios Fourouclas; E Joanna Baxter; Laura R Munro; Dominic A Culligan; Linda M Scott; Anthony R Green
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

5.  The behavior of sex chromosomes in two human X-autosome translocations: failure of extensive X-inactivation spreading.

Authors:  A J Solari; I M Rahn; M E Ferreyra; M A Carballo
Journal:  Biocell       Date:  2001-08       Impact factor: 1.254

Review 6.  Microphthalmia with linear skin defects syndrome in a mosaic female infant with monosomy for the Xp22 region: molecular analysis of the Xp22 breakpoint and the X-inactivation pattern.

Authors:  T Ogata; K Wakui; K Muroya; H Ohashi; N Matsuo; D M Brown; T Ishii; Y Fukushima
Journal:  Hum Genet       Date:  1998-07       Impact factor: 4.132

7.  A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR.

Authors:  T Kubota; S Nonoyama; H Tonoki; M Masuno; K Imaizumi; M Kojima; K Wakui; M Shimadzu; Y Fukushima
Journal:  Hum Genet       Date:  1999-01       Impact factor: 4.132

8.  Attenuated spread of X-inactivation in an X;autosome translocation.

Authors:  Bilyana C Popova; Takashi Tada; Nobuo Takagi; Neil Brockdorff; Tatyana B Nesterova
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-05       Impact factor: 11.205

9.  Atp10a, a gene adjacent to the PWS/AS gene cluster, is not imprinted in mouse and is insensitive to the PWS-IC.

Authors:  Amanda J DuBose; Karen A Johnstone; Emily Y Smith; Ryan A E Hallett; James L Resnick
Journal:  Neurogenetics       Date:  2009-11-06       Impact factor: 2.660

10.  Evidence of influence of genomic DNA sequence on human X chromosome inactivation.

Authors:  Zhong Wang; Huntington F Willard; Sayan Mukherjee; Terrence S Furey
Journal:  PLoS Comput Biol       Date:  2006-07-17       Impact factor: 4.475

View more
  7 in total

1.  De novo unbalanced translocations have a complex history/aetiology.

Authors:  Maria Clara Bonaglia; Nehir Edibe Kurtas; Edoardo Errichiello; Sara Bertuzzo; Silvana Beri; Mana M Mehrjouy; Aldesia Provenzano; Debora Vergani; Vanna Pecile; Francesca Novara; Paolo Reho; Marilena Carmela Di Giacomo; Giancarlo Discepoli; Roberto Giorda; Micheala A Aldred; Cíntia Barros Santos-Rebouças; Andressa Pereira Goncalves; Diane N Abuelo; Sabrina Giglio; Ivana Ricca; Fabrizia Franchi; Philippos Patsalis; Carolina Sismani; María Angeles Morí; Julián Nevado; Niels Tommerup; Orsetta Zuffardi
Journal:  Hum Genet       Date:  2018-10-01       Impact factor: 4.132

2.  Incorporation of 5-ethynyl-2'-deoxyuridine (EdU) as a novel strategy for identification of the skewed X inactivation pattern in balanced and unbalanced X-rearrangements.

Authors:  Luiza Sisdelli; Angela Cristina Vidi; Mariana Moysés-Oliveira; Adriana Di Battista; Adriana Bortolai; Danilo Moretti-Ferreira; Magnus R Dias da Silva; Maria Isabel Melaragno; Gianna Carvalheira
Journal:  Hum Genet       Date:  2015-12-15       Impact factor: 4.132

3.  Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.

Authors:  Zhengang Peng; Rulong Shen; Ying-Wei Li; Kun-Yu Teng; Charles L Shapiro; Huey-Jen L Lin
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

4.  Comparison of Genomic and Epigenomic Expression in Monozygotic Twins Discordant for Rett Syndrome.

Authors:  Kunio Miyake; Chunshu Yang; Yohei Minakuchi; Kenta Ohori; Masaki Soutome; Takae Hirasawa; Yasuhiro Kazuki; Noboru Adachi; Seiko Suzuki; Masayuki Itoh; Yu-Ichi Goto; Tomoko Andoh; Hiroshi Kurosawa; Mitsuo Oshimura; Masayuki Sasaki; Atsushi Toyoda; Takeo Kubota
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

5.  Epigenetic understanding of gene-environment interactions in psychiatric disorders: a new concept of clinical genetics.

Authors:  Takeo Kubota; Kunio Miyake; Takae Hirasawa
Journal:  Clin Epigenetics       Date:  2012-01-20       Impact factor: 6.551

Review 6.  Prader-Willi Syndrome: The Disease that Opened up Epigenomic-Based Preemptive Medicine.

Authors:  Takeo Kubota; Kunio Miyake; Natsuyo Hariya; Vuong Tran Nguyen Quoc; Kazuki Mochizuki
Journal:  Diseases       Date:  2016-03-11

7.  Epigenetic mechanisms and therapeutic perspectives for neurodevelopmental disorders.

Authors:  Takeo Kubota; Hirasawa Takae; Kunio Miyake
Journal:  Pharmaceuticals (Basel)       Date:  2012-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.